Cargando…

THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”

Detalles Bibliográficos
Autores principales:	Retnakumar, Sruthi Vijaya, Bonam, Srinivasa Reddy, Hu, Haitao, Bayry, Jagadeesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965514/ https://www.ncbi.nlm.nih.gov/pubmed/36851261 http://dx.doi.org/10.3390/vaccines11020383

Ejemplares similares

Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines
por: Chauvin, Camille, et al.
Publicado: (2023)

Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2023)

Role of the PD-1 and PD-L1 axis in COVID-19
por: R Bonam, Srinivasa, et al.
Publicado: (2022)

Gasdermin D as a cellular switch to orientate immune responses via IL-33 or IL-1β
por: Chauvin, Camille, et al.
Publicado: (2022)

Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy
por: Bayry, Jagadeesh
Publicado: (2013)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2020)

IFN-γ Induces PD-L1 Expression in Primed Human Basophils
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2022)

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2020)

Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action
por: Wilson, Heather L., et al.
Publicado: (2021)

SARS-CoV-2 Induces Cytokine Responses in Human Basophils
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2022)

Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway
por: Karnam, Anupama, et al.
Publicado: (2021)

Heat Shock Proteins 90 kDa: Immunomodulators and Adjuvants in Vaccine Design Against Infectious Diseases
por: Corigliano, Mariana G., et al.
Publicado: (2021)

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021)

Emerging viral diseases of livestock in the developing world
por: Bayry, Jagadeesh
Publicado: (2013)

Theme: Infectious Diseases
por: Nayak, Sumitha
Publicado: (2020)

Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022)

Mechanisms of Extracellular Immunomodulation Mediated by Infectious Agents
por: Viejo-Borbolla, Abel, et al.
Publicado: (2017)

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
por: Swetha, K., et al.
Publicado: (2023)

Recent Advances of Vaccine Adjuvants for Infectious Diseases
por: Lee, Sujin, et al.
Publicado: (2015)

Autoimmunity as a Predisposition for Infectious Diseases
por: Maddur, Mohan S., et al.
Publicado: (2010)

Novel Vaccine Adjuvants
por: Agrawal, Anshu, et al.
Publicado: (2013)

Next Generation Vaccines for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2019)

Vaccines against Infectious Diseases and Cancer
por: Sousa, Ângela, et al.
Publicado: (2022)

IL-3 produced by T cells is crucial for basophil extravasation in hapten-induced allergic contact dermatitis
por: Hachem, Carole El, et al.
Publicado: (2023)

Corrigendum: IL-3 produced by T cells is crucial for basophil extravasation in hapten- induced allergic contact dermatitis
por: Hachem, Carole El, et al.
Publicado: (2023)

Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination
por: Bosschem, Iris, et al.
Publicado: (2015)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

Arenaviral vaccine vectors to combat infectious diseases
por: Dhanwani, Rekha, et al.
Publicado: (2016)

Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
por: Kotraiah, Vinayaka, et al.
Publicado: (2020)

Recurring Themes
por: Imperiale, Michael J.
Publicado: (2020)

Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease
por: Lim, Yong Taik
Publicado: (2015)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
por: Bayry, Jagadeesh, et al.
Publicado: (2004)

Harnessing Nanoparticles for Immunomodulation and Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

Prolapse themed edition
por: Rogers, R. G.
Publicado: (2021)

Adapting an Infectious Diseases Course for “Engaged Citizen” Themes
por: Senchina, David S.
Publicado: (2016)

Molecular therapies and vaccines face the challenges of emerging infectious diseases
por: Patel, Ami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pd0rqhs3soprpa638b0q8kvupi